Revolution Medicines Inc. (RVMD): Price and Financial Metrics

Revolution Medicines Inc. (RVMD): $38.62

1.12 (-2.82%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add RVMD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#288 of 351

in industry

RVMD Price/Volume Stats

Current price $38.62 52-week high $41.21
Prev. close $39.74 52-week low $15.44
Day low $37.90 Volume 844,900
Day high $39.50 Avg. volume 1,308,965
50-day MA $37.74 Dividend yield N/A
200-day MA $30.12 Market Cap 6.37B

RVMD Stock Price Chart Interactive Chart >


Revolution Medicines Inc. (RVMD) Company Bio


Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.


RVMD Latest News Stream


Event/Time News Detail
Loading, please wait...

RVMD Latest Social Stream


Loading social stream, please wait...

View Full RVMD Social Stream

Latest RVMD News From Around the Web

Below are the latest news stories about REVOLUTION MEDICINES INC that investors may wish to consider to help them evaluate RVMD as an investment opportunity.

Revolution Medicines Inc Insider Sells Shares

Margaret Horn, COO of Revolution Medicines Inc (NASDAQ:RVMD), sold 7,993 shares of the company on December 18, 2023, according to a recent SEC Filing.

Yahoo | December 21, 2023

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

John Blankenhorn on InvestorPlace | December 15, 2023

Insider Sell Alert: COO Margaret Horn Sells 5,000 Shares of Revolution Medicines Inc (RVMD)

In the realm of biopharmaceuticals, insider transactions are often scrutinized for insights into the company's health and future prospects.

Yahoo | December 10, 2023

A great week that adds to Revolution Medicines, Inc.'s (NASDAQ:RVMD) one-year returns, institutional investors who own 74% must be happy

Key Insights Given the large stake in the stock by institutions, Revolution Medicines' stock price might be vulnerable...

Yahoo | November 17, 2023

3 Biotech Stocks That Could Boom or Bust by 2025

Biotech stocks are popular with investors because they sometimes provide tremendous rewards.

Will Ashworth on InvestorPlace | November 16, 2023

Read More 'RVMD' Stories Here

RVMD Price Returns

1-mo -2.00%
3-mo 24.82%
6-mo 45.30%
1-year 56.86%
3-year 13.45%
5-year N/A
YTD 34.66%
2023 20.40%
2022 -5.36%
2021 -36.42%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!